Skip to main content

Ani Pharmaceuticals Inc

ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001023024

In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 10 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Ani Pharmaceuticals Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
138
+14 vs. Q4 2022
Shares held
10.4M
+198.3K (+2.0%) vs. Q4 2022
Total value
$411.7M
+$2.68M (+0.7%) vs. Q4 2022
New holders
26
34 more added
Sold out
12
50 more reduced

2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ANIP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 138 institutions
Q1 2021: 106 institutionsQ2 2021: 116 institutionsQ3 2021: 118 institutionsQ4 2021: 132 institutionsQ1 2022: 126 institutionsQ2 2022: 120 institutionsQ3 2022: 126 institutionsQ4 2022: 126 institutionsQ1 2023: 138 institutionsQ2 2023: 172 institutionsQ3 2023: 186 institutionsQ4 2023: 181 institutionsQ1 2024: 200 institutionsQ2 2024: 201 institutionsQ3 2024: 208 institutionsQ4 2024: 206 institutionsQ1 2025: 231 institutionsQ2 2025: 233 institutionsQ3 2025: 269 institutionsQ4 2025: 285 institutionsQ1 2026: 281 institutionsQ2 2026: 307 institutions
Value heldQ1 2023: $411.7M
Q1 2021: $263.5MQ2 2021: $252.7MQ3 2021: $238.8MQ4 2021: $413.4MQ1 2022: $258.8MQ2 2022: $293.4MQ3 2022: $330.3MQ4 2022: $412.4MQ1 2023: $411.7MQ2 2023: $662.5MQ3 2023: $766.4MQ4 2023: $750.8MQ1 2024: $975.2MQ2 2024: $962.3MQ3 2024: $1.12BQ4 2024: $1.07BQ1 2025: $1.34BQ2 2025: $1.29BQ3 2025: $1.87BQ4 2025: $1.67BQ1 2026: $1.80BQ2 2026: $1.90B
Institutions holding ANIP and their total value by quarter
QuarterHoldersValue
Q2 2026307$1.90B
Q1 2026281$1.80B
Q4 2025285$1.67B
Q3 2025269$1.87B
Q2 2025233$1.29B
Q1 2025231$1.34B
Q4 2024206$1.07B
Q3 2024208$1.12B
Q2 2024201$962.3M
Q1 2024200$975.2M
Q4 2023181$750.8M
Q3 2023186$766.4M
Q2 2023172$662.5M
Q1 2023138$411.7M
Q4 2022126$412.4M
Q3 2022126$330.3M
Q2 2022120$293.4M
Q1 2022126$258.8M
Q4 2021132$413.4M
Q3 2021118$238.8M
Q2 2021116$252.7M
Q1 2021106$263.5M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Ani Pharmaceuticals Inc; share changes are against Q4 2022.

Institutions holding ANIP in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Legal & General Group Plc29,322$1.16M0.00%−426−1.4%Reduced
Schonfeld Strategic Advisors LLC29,750$1.18M0.01%−10,096−25.3%Reduced
Rhumbline Advisers33,985$1.35M0.00%+2,382+7.5%Added
Charles Schwab Investment Management Inc35,039$1.39M0.00%+384+1.1%Added
Jacobs Levy Equity Management, Inc35,108$1.39M0.01%+35,108New
Nuveen Asset Management, LLC40,940$1.63M0.00%−3,977−8.9%Reduced
JPMorgan Chase & Co43,539$1.73M0.00%+4,427+11.3%Added
Great Lakes Advisors, LLC52,095$2.07M0.02%+52,095New
Invesco Ltd.66,092$2.63M0.00%−6,385−8.8%Reduced
Goldman Sachs Group Inc67,149$2.67M0.00%−5,237−7.2%Reduced
Russell Investments Group, Ltd.75,085$2.98M0.01%−9,574−11.3%Reduced
Phocas Financial Corp.75,704$3.01M0.43%+75,704New
Principal Financial Group Inc76,631$3.04M0.00%−963−1.2%Reduced
Marathon Capital Management84,890$3.37M0.83%+12,000+16.5%Added
Worth Venture Partners, LLC85,558$3.40M1.67%−2,459−2.8%Reduced
Parkman Healthcare Partners LLC100,000$3.97M0.86%−26,874−21.2%Reduced
Loomis Sayles & Co L P104,012$4.13M0.01%+104,012New
Morgan Stanley104,141$4.14M0.00%+2,929+2.9%Added
Bank of New York Mellon Corp109,489$4.35M0.00%−4,608−4.0%Reduced
Wedge Capital Management L L P118,945$4.72M0.08%−5,325−4.3%Reduced
Ranger Investment Management, L.P.125,556$4.99M0.33%+4,370+3.6%Added
Brandywine Global Investment Management, LLC129,853$5.16M0.04%+2,185+1.7%Added
Northern Trust Corp139,842$5.55M0.00%−1,672−1.2%Reduced
First Wilshire Securities Management Inc206,328$8.20M2.80%−155,119−42.9%Reduced
Geode Capital Management, LLC245,105$9.74M0.00%+5,756+2.4%Added
Kennedy Capital Management, Inc.282,621$11.2M0.33%−77,873−21.6%Reduced
Ameriprise Financial Inc301,565$12.0M0.00%−300.0%Reduced
Emerald Mutual Fund Advisers Trust306,277$12.2M0.72%−25,414−7.7%Reduced
AIGH Capital Management LLC348,106$13.8M5.10%−10,000−2.8%Reduced
Emerald Advisers, LLC373,406$14.8M0.71%−69,830−15.8%Reduced
Thompson Siegel & Walmsley LLC393,789$15.6M0.25%−21,491−5.2%Reduced
State Street Corp460,172$18.3M0.00%+12,185+2.7%Added
Global Alpha Capital Management Ltd.462,961$18.4M1.67%+13,430+3.0%Added
William Blair Investment Management, LLC529,130$21.0M0.07%+1,665+0.3%Added
Dimensional Fund Advisors LP531,192$21.1M0.01%+4,116+0.8%Added
Rubric Capital Management LP648,041$25.7M1.03%+271,909+72.3%Added
Vanguard Group Inc834,210$33.1M0.00%+21,586+2.7%Added
BlackRock Inc.1,941,698$77.1M0.00%−41,907−2.1%Reduced
VGI Partners Ltd0$00.00%−25,000−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−8,744−100.0%Sold out
Cambridge Investment Research Advisors, Inc.0$00.00%−5,325−100.0%Sold out
Voya Investment Management LLC0$00.00%−5,019−100.0%Sold out
Shell Asset Management Co0$00.00%−2,644−100.0%Sold out
Lazard Asset Management LLC0$00.00%−1,371−100.0%Sold out
DT Investment Partners, LLC0$00.00%−1,280−100.0%Sold out
Simplex Trading, LLC0$00.00%−1,144−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−72−100.0%Sold out
Global Retirement Partners, LLC0$00.00%−12−100.0%Sold out
Sutton Wealth Advisors Inc.0$00.00%−4−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−6−100.0%Sold out
Comerica Bank––––Not filed
Rothschild & Co Asset Management US Inc.––––Not filed